175 related articles for article (PubMed ID: 32818476)
1. Cost of care for the initial management of cervical cancer in women with commercial insurance.
Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
[TBL] [Abstract][Full Text] [Related]
2. Cost of Care for the Initial Management of Ovarian Cancer.
Bercow AS; Chen L; Chatterjee S; Tergas AI; Hou JY; Burke WM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Obstet Gynecol; 2017 Dec; 130(6):1269-1275. PubMed ID: 29112648
[TBL] [Abstract][Full Text] [Related]
3. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
Lairson DR; Fu S; Chan W; Xu L; Shelal Z; Ramondetta L
Gynecol Oncol; 2017 Apr; 145(1):108-113. PubMed ID: 28196673
[TBL] [Abstract][Full Text] [Related]
4. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.
Farias AJ; Hansen RN; Zeliadt SB; Ornelas IJ; Li CI; Thompson B
Am J Clin Oncol; 2018 Jul; 41(7):708-715. PubMed ID: 27893470
[TBL] [Abstract][Full Text] [Related]
6. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
[TBL] [Abstract][Full Text] [Related]
7. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
[TBL] [Abstract][Full Text] [Related]
8. Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
Suidan RS; He W; Sun CC; Zhao H; Rauh-Hain JA; Fleming ND; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Aug; 221(2):136.e1-136.e9. PubMed ID: 30965052
[TBL] [Abstract][Full Text] [Related]
9. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
10. Expenditures and Health Care Utilization Among Adults With Newly Diagnosed Low Back and Lower Extremity Pain.
Kim LH; Vail D; Azad TD; Bentley JP; Zhang Y; Ho AL; Fatemi P; Feng A; Varshneya K; Desai M; Veeravagu A; Ratliff JK
JAMA Netw Open; 2019 May; 2(5):e193676. PubMed ID: 31074820
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
12. Cost of Treatment for Cervical Cancer in India.
Singh MP; Chauhan AS; Rai B; Ghoshal S; Prinja S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2639-2646. PubMed ID: 32986363
[TBL] [Abstract][Full Text] [Related]
13. Direct costs of cervical cancer management in Morocco.
Berraho M; Najdi A; Mathoulin-Pelissier S; Salamon R; Nejjari C
Asian Pac J Cancer Prev; 2012; 13(7):3159-63. PubMed ID: 22994727
[TBL] [Abstract][Full Text] [Related]
14. Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
Ricciardi A; Largeron N; Giorgi Rossi P; Raffaele M; Cohet C; Federici A; Palazzo F
Tumori; 2009; 95(2):146-52. PubMed ID: 19579858
[TBL] [Abstract][Full Text] [Related]
15. A cost comparison of two strategies for treating stage IB2 cervical cancer.
Lachance JA; Darus CJ; Stukenborg GJ; Schneider BF; Rice LW; Jazaeri AA
Int J Gynecol Cancer; 2008; 18(2):274-8. PubMed ID: 18334009
[TBL] [Abstract][Full Text] [Related]
16. Cost Analysis of Cervical Cancer Patients with Different Medical Payment Modes Based on Gamma Model within a Grade A Tertiary Hospital.
Wu SW; Chen T; Pan Q; Wei LY; Wang Q; Song JC; Li C; Luo J
Chin Med J (Engl); 2018 Feb; 131(4):389-394. PubMed ID: 29451142
[TBL] [Abstract][Full Text] [Related]
17. Out-of-network bills among privately insured patients undergoing hysterectomy.
Albright BB; Chen L; Havrilesky LJ; Moss HA; Wright JD
Am J Obstet Gynecol; 2022 Apr; 226(4):543.e1-543.e45. PubMed ID: 34774823
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy costs with commercial insurance.
Rahman M; Chen L; Daw J; Wright JD; D'Alton ME; Wen T; Friedman AM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10143-10151. PubMed ID: 36104042
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
20. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
